title: Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
abstract: BACKGROUND
  Longitudinal growth and bone age (BA) development are the most important clinical parameters for monitoring adequate glucocorticoid replacement in children with congenital adrenal hyperplasia (CAH).
  
  
  OBJECTIVE
  To analyze the growth pattern of patients treated for CAH of the salt wasting (SW) and simple virilizing (SV) clinical forms; to evaluate final height as compared to reference data and individual target height; to evaluate the course of BA development.
  
  
  METHODS
  A large database of 598 patients with CAH was created in 5 Central European countries and growth data of 341 treated patients with 21-hydroxylase deficiency were analyzed retrospectively. The patients were of Caucasian origin. Centiles were constructed in a cross-sectional manner and an additional longitudinal analysis was performed in order to evaluate the pubertal growth spurt by applying particular statistical methods (Preece-Baines model).
  
  
  RESULTS
  The growth of SW CAH patients was impaired in infancy and early childhood (0-3 years of age), but followed normal patterns in childhood until puberty. In contrast, children with SV CAH had normal patterns of growth in infancy and early childhood and were considerably taller than healthy references during childhood. In the longitudinal study, peak height velocity in both boys and girls was normal, but it occurred at an earlier age than in the standard population. The final height of patients with CAH was reduced in comparison to both the reference and the individual target height. No correlations were found between final height and age at the start of the therapy in SV patients or between final height and year of birth. BA was advanced in both types of CAH, but more accelerated in SV patients.
  
  
  CONCLUSIONS
  Characteristic growth patterns for treated SV and SW CAH children were identified, with a normal pubertal growth spurt and reduced final height being observed.
authors.affiliation: 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
authors.forename: G
authors.initials: G
authors.lastname: Hargitai
authors.forename: J
authors.initials: J
authors.lastname: Sólyom
authors.forename: T
authors.initials: T
authors.lastname: Battelino
authors.forename: J
authors.initials: J
authors.lastname: Lebl
authors.forename: Z
authors.initials: Z
authors.lastname: Pribilincová
authors.forename: R
authors.initials: R
authors.lastname: Hauspie
authors.forename: J
authors.initials: J
authors.lastname: Kovács
authors.forename: F
authors.initials: F
authors.lastname: Waldhauser
authors.forename: H
authors.initials: H
authors.lastname: Frisch
mesh_terms: D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology*; D000365:Age Determination by Skeleton / Q000379:methods; D001827:Body Height / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D005260:Female; D006130:Growth Disorders / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008137:Longitudinal Studies; D008297:Male; D011627:Puberty / Q000235:genetics; D012189:Retrospective Studies